The pharmaceutical industry plays an important role in drug development, but we are concerned about its growing control over academic research, drug regulation and legislation, and medical education, including medical conferences and medical publications. Like all corporations, pharmaceutical companies are dedicated to making money. This is problematic only when there is insufficient counter-balance from institutions designed to protect the public good.
This website has been designed to allow professionals to express views that are not necessarily favorable to the pharmaceutical industry and that have generally received little hearing in drug-company sponsored publications. The essay Avastin vs. Lucentis: Why It Matters exemplifies our core concerns. We welcome comments and submissions via the links above.
No comments:
Post a Comment